Glenmark Pharmaceuticals Limited, incorporated in 1977, is focused on the manufacture and marketing of formulation products and active pharmaceutical ingredients [API] in India as well as globally. Over the past five years, the company has also catalysed its growth through investment in dedicated research and development including cutting-edge New Chemical Entity [NCE] research. Glenmark established its operations in Brazil in FY 2004 and acquired a company in early FY 2005. The company also incorporated subsidiaries in the regulated markets of USA in FY 2003 and EU in FY 2005.